Verinurad and febuxostat combo intensively lowers urates and reduces Albuminuria
Researchers have found in a new study that Intensive urate lowering by Verinurad and febuxostat combination is linked to reduced urine albumin excretion.
Hyperuricemia has been implicated in the development and progression of chronic kidney disease (CKD).
People with chronic kidney disease and type 2 diabetes are at risk for deteriorating kidney function and progressive chronic kidney disease (CKD).Loss of albumin into the urine is an early marker of kidney damage and is associated with further deterioration.Albuminuria is the earliest clinical signal of kidney disease in diabetic nephropathy and strategies that reduce albuminuria, such as RAS inhibition, are standard of care.
Verinurad is a novel, potent, specific urate reabsorption inhibitor. Researchers evaluated the effects of intensive urate-lowering therapy with verinurad combined with the xanthine oxidase (XO) inhibitor febuxostat on albuminuria in patients with hyperuricemia and type 2 diabetes mellitus (T2DM).
This proof-of-concept study showed that treatment with verinurad 9 mg plus febuxostat 80 mg once daily reduced albuminuria in patients with T2DM and hyperuricemia receiving standard-of-care renoprotective treatment and optimal antihypertensive therapy.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.